Macrophage membrane camouflaged reactive oxygen species responsive nanomedicine for efficiently inhibiting the vascular intimal hyperplasia
Abstract Background Intimal hyperplasia caused by vascular injury is an important pathological process of many vascular diseases, especially occlusive vascular disease. In recent years, Nano-drug delivery system has attracted a wide attention as a novel treatment strategy, but there are still some c...
Guardado en:
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
BMC
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/de17b6f5adb5453baabb43715c6d3fe3 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:de17b6f5adb5453baabb43715c6d3fe3 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:de17b6f5adb5453baabb43715c6d3fe32021-11-21T12:29:28ZMacrophage membrane camouflaged reactive oxygen species responsive nanomedicine for efficiently inhibiting the vascular intimal hyperplasia10.1186/s12951-021-01119-51477-3155https://doaj.org/article/de17b6f5adb5453baabb43715c6d3fe32021-11-01T00:00:00Zhttps://doi.org/10.1186/s12951-021-01119-5https://doaj.org/toc/1477-3155Abstract Background Intimal hyperplasia caused by vascular injury is an important pathological process of many vascular diseases, especially occlusive vascular disease. In recent years, Nano-drug delivery system has attracted a wide attention as a novel treatment strategy, but there are still some challenges such as high clearance rate and insufficient targeting. Results In this study, we report a biomimetic ROS-responsive MM@PCM/RAP nanoparticle coated with macrophage membrane. The macrophage membrane with the innate “homing” capacity can superiorly regulate the recruitment of MM@PCM/RAP to inflammatory lesion to enhance target efficacy, and can also disguise MM@PCM/RAP nanoparticle as the autologous cell to avoid clearance by the immune system. In addition, MM@PCM/RAP can effectively improve the solubility of rapamycin and respond to the high concentration level of ROS accumulated in pathological lesion for controlling local cargo release, thereby increasing drug availability and reducing toxic side effects. Conclusions Our findings validate that the rational design, biomimetic nanoparticles MM@PCM/RAP, can effectively inhibit the pathological process of intimal injury with excellent biocompatibility. Graphical AbstractBoyan LiuWenhua YanLi LuoShuai WuYi WangYuan ZhongDan TangAli MarufMeng YanKun ZhangXian QinKai QuWei WuGuixue WangBMCarticleIntimal hyperplasiaNanomedicineTargeted deliveryMacrophagesROS-responsiveBiotechnologyTP248.13-248.65Medical technologyR855-855.5ENJournal of Nanobiotechnology, Vol 19, Iss 1, Pp 1-19 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Intimal hyperplasia Nanomedicine Targeted delivery Macrophages ROS-responsive Biotechnology TP248.13-248.65 Medical technology R855-855.5 |
spellingShingle |
Intimal hyperplasia Nanomedicine Targeted delivery Macrophages ROS-responsive Biotechnology TP248.13-248.65 Medical technology R855-855.5 Boyan Liu Wenhua Yan Li Luo Shuai Wu Yi Wang Yuan Zhong Dan Tang Ali Maruf Meng Yan Kun Zhang Xian Qin Kai Qu Wei Wu Guixue Wang Macrophage membrane camouflaged reactive oxygen species responsive nanomedicine for efficiently inhibiting the vascular intimal hyperplasia |
description |
Abstract Background Intimal hyperplasia caused by vascular injury is an important pathological process of many vascular diseases, especially occlusive vascular disease. In recent years, Nano-drug delivery system has attracted a wide attention as a novel treatment strategy, but there are still some challenges such as high clearance rate and insufficient targeting. Results In this study, we report a biomimetic ROS-responsive MM@PCM/RAP nanoparticle coated with macrophage membrane. The macrophage membrane with the innate “homing” capacity can superiorly regulate the recruitment of MM@PCM/RAP to inflammatory lesion to enhance target efficacy, and can also disguise MM@PCM/RAP nanoparticle as the autologous cell to avoid clearance by the immune system. In addition, MM@PCM/RAP can effectively improve the solubility of rapamycin and respond to the high concentration level of ROS accumulated in pathological lesion for controlling local cargo release, thereby increasing drug availability and reducing toxic side effects. Conclusions Our findings validate that the rational design, biomimetic nanoparticles MM@PCM/RAP, can effectively inhibit the pathological process of intimal injury with excellent biocompatibility. Graphical Abstract |
format |
article |
author |
Boyan Liu Wenhua Yan Li Luo Shuai Wu Yi Wang Yuan Zhong Dan Tang Ali Maruf Meng Yan Kun Zhang Xian Qin Kai Qu Wei Wu Guixue Wang |
author_facet |
Boyan Liu Wenhua Yan Li Luo Shuai Wu Yi Wang Yuan Zhong Dan Tang Ali Maruf Meng Yan Kun Zhang Xian Qin Kai Qu Wei Wu Guixue Wang |
author_sort |
Boyan Liu |
title |
Macrophage membrane camouflaged reactive oxygen species responsive nanomedicine for efficiently inhibiting the vascular intimal hyperplasia |
title_short |
Macrophage membrane camouflaged reactive oxygen species responsive nanomedicine for efficiently inhibiting the vascular intimal hyperplasia |
title_full |
Macrophage membrane camouflaged reactive oxygen species responsive nanomedicine for efficiently inhibiting the vascular intimal hyperplasia |
title_fullStr |
Macrophage membrane camouflaged reactive oxygen species responsive nanomedicine for efficiently inhibiting the vascular intimal hyperplasia |
title_full_unstemmed |
Macrophage membrane camouflaged reactive oxygen species responsive nanomedicine for efficiently inhibiting the vascular intimal hyperplasia |
title_sort |
macrophage membrane camouflaged reactive oxygen species responsive nanomedicine for efficiently inhibiting the vascular intimal hyperplasia |
publisher |
BMC |
publishDate |
2021 |
url |
https://doaj.org/article/de17b6f5adb5453baabb43715c6d3fe3 |
work_keys_str_mv |
AT boyanliu macrophagemembranecamouflagedreactiveoxygenspeciesresponsivenanomedicineforefficientlyinhibitingthevascularintimalhyperplasia AT wenhuayan macrophagemembranecamouflagedreactiveoxygenspeciesresponsivenanomedicineforefficientlyinhibitingthevascularintimalhyperplasia AT liluo macrophagemembranecamouflagedreactiveoxygenspeciesresponsivenanomedicineforefficientlyinhibitingthevascularintimalhyperplasia AT shuaiwu macrophagemembranecamouflagedreactiveoxygenspeciesresponsivenanomedicineforefficientlyinhibitingthevascularintimalhyperplasia AT yiwang macrophagemembranecamouflagedreactiveoxygenspeciesresponsivenanomedicineforefficientlyinhibitingthevascularintimalhyperplasia AT yuanzhong macrophagemembranecamouflagedreactiveoxygenspeciesresponsivenanomedicineforefficientlyinhibitingthevascularintimalhyperplasia AT dantang macrophagemembranecamouflagedreactiveoxygenspeciesresponsivenanomedicineforefficientlyinhibitingthevascularintimalhyperplasia AT alimaruf macrophagemembranecamouflagedreactiveoxygenspeciesresponsivenanomedicineforefficientlyinhibitingthevascularintimalhyperplasia AT mengyan macrophagemembranecamouflagedreactiveoxygenspeciesresponsivenanomedicineforefficientlyinhibitingthevascularintimalhyperplasia AT kunzhang macrophagemembranecamouflagedreactiveoxygenspeciesresponsivenanomedicineforefficientlyinhibitingthevascularintimalhyperplasia AT xianqin macrophagemembranecamouflagedreactiveoxygenspeciesresponsivenanomedicineforefficientlyinhibitingthevascularintimalhyperplasia AT kaiqu macrophagemembranecamouflagedreactiveoxygenspeciesresponsivenanomedicineforefficientlyinhibitingthevascularintimalhyperplasia AT weiwu macrophagemembranecamouflagedreactiveoxygenspeciesresponsivenanomedicineforefficientlyinhibitingthevascularintimalhyperplasia AT guixuewang macrophagemembranecamouflagedreactiveoxygenspeciesresponsivenanomedicineforefficientlyinhibitingthevascularintimalhyperplasia |
_version_ |
1718418976284868608 |